C07J 5/00

Technology



back to "C07J 5/00" profile

More Results

Showing 1 to 20 of 220 results

Patent/Pub #TitleFiling DateIssue/Publication DatePatent Owner
9975918 Highly potent glucocorticoidsSep 25, 14May 22, 18Van Andel Research Institute; Shanghai Institute of Materia Medica Chinese Academy of Sciences;
9895379 17alpha, 21-dihydroxypregnene esters as antiandrogenic agentsOct 16, 15Feb 20, 18CASSIOPEA S.P.A.
9877972 Treatment methods using pharmaceutical solid state formsAug 14, 14Jan 30, 18NEURMEDIX, INC.
9815865 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereofNov 13, 13Nov 14, 17NICOX OPHTHALMICS, INC.
9783569 Method for preparing 6-alkylated steroidal derivatives and corresponding alkylated 5,6,7,8-tetrahydronaphthalene-2(4 alpha.H)-onesOct 28, 14Oct 10, 17SANOFI
9717743 Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivativesSep 12, 14Aug 01, 17ALLERGAN, INC.
9683007 Methods for the purification of deoxycholic acidNov 04, 14Jun 20, 17Kythera Biopharmaceuticals, Inc.
9683010 Process for the production of 21-methoxy-11-beta-phenyl-19-nor-pregna-4,9-diene-3,20-dione derivativesFeb 16, 15Jun 20, 17RICHTER GEDEON NYRT.
9676812 Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameDec 18, 13Jun 13, 17SAGE THERAPEUTICS, INC., WASHINGTON UNIVERSITY,
9676814 Industrial process for the synthesis of ulipristal acetate and its 4′-acetyl analogueOct 01, 14Jun 13, 17RICHTER GEDEON NYRT.
9650408 Therapeutic agent for hypertensionAug 28, 06May 16, 17SRI INTERNATIONAL
9649320 Non-hormonal steroid modulators of NF-κB for treatment of diseaseAug 05, 16May 16, 17Reveragen Biopharma, Inc
9630986 Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using sameDec 18, 13Apr 25, 17SAGE THERAPEUTICS, INC., WASHINGTON UNIVERSITY,
9555046 Crystalline anhydrate forms of a pharmaceuticalAug 14, 14Jan 31, 17NEURMEDIX, INC.
9512165 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereofApr 17, 14Dec 06, 16SAGE THERAPEUTICS, INC.
9504699 Delayed-release glucocorticoid treatment of rheumatoid diseaseDec 08, 14Nov 29, 16HZNP LIMITED
9486458 Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivativesOct 19, 15Nov 08, 16CASSIOPEA S.P.A.
9433628 Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivativesNov 07, 13Sep 06, 16CASSIOPEA S.P.A.
9433631 4-pregenen-11β-17-21-triol-3,20-dione derivativesNov 05, 14Sep 06, 16ALLERGAN, INC.
9434758 Non-hormonal steroid modulators of NF-κB for treatment of diseaseJan 27, 14Sep 06, 16Reveragen Biopharma, Inc

Showing 1 to 20 of 220 results